BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37591659)

  • 1. Decoding B cell receptors in autoimmune diseases.
    Atisha-Fregoso Y; Diamond B
    Ann Rheum Dis; 2023 Nov; 82(11):1369-1370. PubMed ID: 37591659
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity.
    Burbelo PD; Iadarola MJ; Keller JM; Warner BM
    Front Immunol; 2021; 12():548469. PubMed ID: 33763057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity to neuronal nicotinic acetylcholine receptors.
    Pechlivanidou M; Ninou E; Karagiorgou K; Tsantila A; Mantegazza R; Francesca A; Furlan R; Dudeck L; Steiner J; Tzartos J; Tzartos S
    Pharmacol Res; 2023 Jun; 192():106790. PubMed ID: 37164280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes.
    Hampe CS
    Autoimmunity; 2012 Jun; 45(4):320-31. PubMed ID: 22288464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies.
    Meffre E; O'Connor KC
    Immunol Rev; 2019 Nov; 292(1):90-101. PubMed ID: 31721234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Cell-Mediated Autoimmune Diseases.
    Lin X; Lu L
    Adv Exp Med Biol; 2020; 1254():145-160. PubMed ID: 32323275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial autoimmunity participates in the regulation of rheumatoid arthritis.
    Zohar Y; Wildbaum G; Karin N
    Front Biosci; 2006 Jan; 11():368-79. PubMed ID: 16146738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of B cell metabolism in autoimmune diseases.
    Mubariki R; Vadasz Z
    Autoimmun Rev; 2022 Jul; 21(7):103116. PubMed ID: 35595053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR7 and IgM: Dangerous Partners in Autoimmunity.
    Amendt T; Yu P
    Antibodies (Basel); 2023 Jan; 12(1):. PubMed ID: 36648888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.
    Ettinger R; Karnell JL; Henault J; Panda SK; Riggs JM; Kolbeck R; Sanjuan MA
    Autoimmunity; 2017 Feb; 50(1):25-36. PubMed ID: 28166684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity and its association with regulatory T cells and B cell subsets in patients with common variable immunodeficiency.
    Azizi G; Abolhassani H; Kiaee F; Tavakolinia N; Rafiemanesh H; Yazdani R; Mahdaviani SA; Mohammadikhajehdehi S; Tavakol M; Ziaee V; Negahdari B; Mohammadi J; Mirshafiey A; Aghamohammadi A
    Allergol Immunopathol (Madr); 2018; 46(2):127-135. PubMed ID: 28735808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic autoantigens of immunoglobulins and T-cell receptors: their recognition in aging, infection, and autoimmunity.
    Marchalonis JJ; Schluter SF; Wang E; Dehghanpisheh K; Lake D; Yocum DE; Edmundson AB; Winfield JB
    Proc Soc Exp Biol Med; 1994 Nov; 207(2):129-47. PubMed ID: 7938045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches.
    Merino-Vico A; Frazzei G; van Hamburg JP; Tas SW
    Eur J Immunol; 2023 Jan; 53(1):e2149675. PubMed ID: 36314264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.
    Baert L; Manfroi B; Casez O; Sturm N; Huard B
    J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin.
    Ahmed AR; Kaveri S
    Front Immunol; 2018; 9():1189. PubMed ID: 30072982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell checkpoints in autoimmune rheumatic diseases.
    Rubin SJS; Bloom MS; Robinson WH
    Nat Rev Rheumatol; 2019 May; 15(5):303-315. PubMed ID: 30967621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ets1 and IL17RA cooperate to regulate autoimmune responses and skin immunity to
    Battaglia M; Sunshine AC; Luo W; Jin R; Stith A; Lindemann M; Miller LS; Sinha S; Wohlfert E; Garrett-Sinha LA
    Front Immunol; 2023; 14():1208200. PubMed ID: 37691956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.